These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20090941)

  • 1. Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A.
    Rosada RS; Moreira AP; Frantz FG; Puri RK; Rahman A; Standiford TJ; Zárate-Bladés CR; Silva CL; Hogaboam CM
    PLoS One; 2010 Jan; 5(1):e8721. PubMed ID: 20090941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.
    Nagai T; Tanaka M; Hasui K; Shirahama H; Kitajima S; Yonezawa S; Xu B; Matsuyama T
    Clin Exp Immunol; 2010 Aug; 161(2):348-56. PubMed ID: 20550546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.
    Weldon JE; Pastan I
    FEBS J; 2011 Dec; 278(23):4683-700. PubMed ID: 21585657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis.
    Jakubzick C; Kunkel SL; Puri RK; Hogaboam CM
    Immunol Res; 2004; 30(3):339-49. PubMed ID: 15531774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cintredekin besudotox in treatment of malignant glioma.
    Mut M; Sherman JH; Shaffrey ME; Schiff D
    Expert Opin Biol Ther; 2008 Jun; 8(6):805-12. PubMed ID: 18476792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft.
    Husain SR; Puri RK
    Blood; 2000 Jun; 95(11):3506-13. PubMed ID: 10828036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice.
    Blease K; Jakubzick C; Schuh JM; Joshi BH; Puri RK; Hogaboam CM
    J Immunol; 2001 Dec; 167(11):6583-92. PubMed ID: 11714828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells.
    Jakubzick C; Choi ES; Joshi BH; Keane MP; Kunkel SL; Puri RK; Hogaboam CM
    J Immunol; 2003 Sep; 171(5):2684-93. PubMed ID: 12928422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pseudomonas aeruginosa recombinant proteins: effect on mice cytokine profile].
    Soldatenkova AV; Geĭderova LA; Akhmatova NK; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (6):80-7. PubMed ID: 24605680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR).
    Puri RK; Leland P; Obiri NI; Husain SR; Kreitman RJ; Haas GP; Pastan I; Debinski W
    Blood; 1996 May; 87(10):4333-9. PubMed ID: 8639793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Resistance to Immunotoxins Containing
    Dieffenbach M; Pastan I
    Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32630017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.
    Wolf P; Elsässer-Beile U
    Int J Med Microbiol; 2009 Mar; 299(3):161-76. PubMed ID: 18948059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotoxins containing Pseudomonas exotoxin A: a short history.
    Pastan I
    Cancer Immunol Immunother; 2003 May; 52(5):338-41. PubMed ID: 12700949
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-13 receptor as a unique target for anti-glioblastoma therapy.
    Husain SR; Joshi BH; Puri RK
    Int J Cancer; 2001 Apr; 92(2):168-75. PubMed ID: 11291041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy.
    Shimamura T; Husain SR; Puri RK
    Neurosurg Focus; 2006 Apr; 20(4):E11. PubMed ID: 16709016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exotoxin A-PLGA nanoconjugate vaccine against Pseudomonas aeruginosa infection: protectivity in murine model.
    Safari Zanjani L; Shapouri R; Dezfulian M; Mahdavi M; Shafiee Ardestani M
    World J Microbiol Biotechnol; 2019 Jun; 35(6):94. PubMed ID: 31187291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of factor VIII-specific B cells by immunotoxins composed of a single factor VIII domain fused to Pseudomonas exotoxin A.
    Brettschneider K; Schmidt A; Kahle J; Orlowski A; Stichel D; Schwabe D; Königs C
    J Thromb Haemost; 2018 Nov; 16(11):2223-2232. PubMed ID: 30152083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin.
    Maini A; Hillman G; Haas GP; Wang CY; Montecillo E; Hamzavi F; Pontes JE; Leland P; Pastan I; Debinski W; Puri RK
    J Urol; 1997 Sep; 158(3 Pt 1):948-53. PubMed ID: 9258124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas exotoxin and recombinant immunotoxins derived from it.
    Fitzgerald D; Pastan I
    Ann N Y Acad Sci; 1993 Jun; 685():740-5. PubMed ID: 8363279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL13 Fused
    Uludağ D; Karakaş N
    Anticancer Res; 2021 Jul; 41(7):3471-3480. PubMed ID: 34230142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.